-
1
-
-
84858784892
-
Targeting natural killer cells and natural killer T cells in cancer
-
Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol. 2012;12(4):239-52.
-
(2012)
Nat Rev Immunol
, vol.12
, Issue.4
, pp. 239-252
-
-
Vivier, E.1
Ugolini, S.2
Blaise, D.3
Chabannon, C.4
Brossay, L.5
-
2
-
-
0030696696
-
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides
-
Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science. 1997;278(5343):1626-9.
-
(1997)
Science
, vol.278
, Issue.5343
, pp. 1626-1629
-
-
Kawano, T.1
Cui, J.2
Koezuka, Y.3
Toura, I.4
Kaneko, Y.5
Motoki, K.6
-
3
-
-
35748954102
-
Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells
-
Shimizu K, Kurosawa Y, Taniguchi M, Steinman RM, Fujii S-I. Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J Exp Med. 2007;204(11):2641-53.
-
(2007)
J Exp Med
, vol.204
, Issue.11
, pp. 2641-2653
-
-
Shimizu, K.1
Kurosawa, Y.2
Taniguchi, M.3
Steinman, R.M.4
Fujii, S.-I.5
-
4
-
-
0037787982
-
Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein
-
Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med. 2003;198(2):267-79.
-
(2003)
J Exp Med
, vol.198
, Issue.2
, pp. 267-279
-
-
Fujii, S.1
Shimizu, K.2
Smith, C.3
Bonifaz, L.4
Steinman, R.M.5
-
5
-
-
10744230210
-
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells
-
Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, et al. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol. 2003;171(10):5140-7.
-
(2003)
J Immunol
, vol.171
, Issue.10
, pp. 5140-5147
-
-
Hermans, I.F.1
Silk, J.D.2
Gileadi, U.3
Salio, M.4
Mathew, B.5
Ritter, G.6
-
6
-
-
77954314391
-
Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand
-
Petersen TR, Sika-Paotonu D, Knight DA, Dickgreber N, Farrand KJ, Ronchese F, et al. Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand. Immunol Cell Biol. 2010;88(5):596-604.
-
(2010)
Immunol Cell Biol
, vol.88
, Issue.5
, pp. 596-604
-
-
Petersen, T.R.1
Sika-Paotonu, D.2
Knight, D.A.3
Dickgreber, N.4
Farrand, K.J.5
Ronchese, F.6
-
7
-
-
28544431840
-
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
-
Liu K, Idoyaga J, Charalambous A, Fujii S, Bonito A, Mordoh J, et al. Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells. J Exp Med. 2005;202(11):1507-16.
-
(2005)
J Exp Med
, vol.202
, Issue.11
, pp. 1507-1516
-
-
Liu, K.1
Idoyaga, J.2
Charalambous, A.3
Fujii, S.4
Bonito, A.5
Mordoh, J.6
-
8
-
-
79953313061
-
Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines
-
Petersen TR, Sika-Paotonu D, Knight DA, Simkins HM, Hermans IF. Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines. PLoS ONE. 2011;6(3):e17657.
-
(2011)
PLoS ONE
, vol.6
, Issue.3
-
-
Petersen, T.R.1
Sika-Paotonu, D.2
Knight, D.A.3
Simkins, H.M.4
Hermans, I.F.5
-
9
-
-
0033526066
-
The natural killer T (NKT) cell ligand alphagalactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
-
Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, Ohmi Y, et al. The natural killer T (NKT) cell ligand alphagalactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med. 1999;189(7):1121-8.
-
(1999)
J Exp Med
, vol.189
, Issue.7
, pp. 1121-1128
-
-
Kitamura, H.1
Iwakabe, K.2
Yahata, T.3
Nishimura, S.4
Ohta, A.5
Ohmi, Y.6
-
10
-
-
35548991084
-
Cellular immune therapy for chronic lymphocytic leukemia
-
Kater AP, van Oers MHJ, Kipps TJ. Cellular immune therapy for chronic lymphocytic leukemia. Blood. 2007;110(8):2811-8.
-
(2007)
Blood
, vol.110
, Issue.8
, pp. 2811-2818
-
-
Kater, A.P.1
van Oers, M.H.J.2
Kipps, T.J.3
-
11
-
-
77950927932
-
Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8(+) T-cell responses in patients with chronic lymphocytic leukemia
-
Giannopoulos K, Dmoszynska A, Kowal M, Rolinski J, Gostick E, Price DA, et al. Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8(+) T-cell responses in patients with chronic lymphocytic leukemia. Leukemia. 2010;24(4): 798-805.
-
(2010)
Leukemia
, vol.24
, Issue.4
, pp. 798-805
-
-
Giannopoulos, K.1
Dmoszynska, A.2
Kowal, M.3
Rolinski, J.4
Gostick, E.5
Price, D.A.6
-
12
-
-
80051720194
-
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia
-
Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011;365(8):725-33.
-
(2011)
N Engl J Med
, vol.365
, Issue.8
, pp. 725-733
-
-
Porter, D.L.1
Levine, B.L.2
Kalos, M.3
Bagg, A.4
June, C.H.5
-
13
-
-
79953814653
-
Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL
-
Christopoulos P, Pfeifer D, Bartholome K, Follo M, Timmer J, Fisch P, et al. Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL. Blood. 2011;117(14):3836-46.
-
(2011)
Blood
, vol.117
, Issue.14
, pp. 3836-3846
-
-
Christopoulos, P.1
Pfeifer, D.2
Bartholome, K.3
Follo, M.4
Timmer, J.5
Fisch, P.6
-
14
-
-
22144489127
-
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells
-
Görgün G, Holderried TAW, Zahrieh D, Neuberg D, Gribben JG. Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J Clin Invest. 2005;115(7):1797-805.
-
(2005)
J Clin Invest
, vol.115
, Issue.7
, pp. 1797-1805
-
-
Görgün, G.1
Holderried, T.A.W.2
Zahrieh, D.3
Neuberg, D.4
Gribben, J.G.5
-
15
-
-
46749132717
-
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
-
Ramsay AG, Johnson AJ, Lee AM, Gorgün G, Le Dieu R, Blum W, et al. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest. 2008;118(7):2427-37.
-
(2008)
J Clin Invest
, vol.118
, Issue.7
, pp. 2427-2437
-
-
Ramsay, A.G.1
Johnson, A.J.2
Lee, A.M.3
Gorgün, G.4
Le Dieu, R.5
Blum, W.6
-
16
-
-
3042588239
-
Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: Influence of neoplastic CD19 cells in vivo and in vitro
-
Orsini E, Pasquale A, Maggio R, Calabrese E, Mauro FR, Giammartini E, et al. Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitro. Br J Haematol. 2004;125(6):720-8.
-
(2004)
Br J Haematol
, vol.125
, Issue.6
, pp. 720-728
-
-
Orsini, E.1
Pasquale, A.2
Maggio, R.3
Calabrese, E.4
Mauro, F.R.5
Giammartini, E.6
-
17
-
-
0036896332
-
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors
-
Giaccone G, Punt CJA, Ando Y, Ruijter R, Nishi N, Peters M, et al. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res. 2002;8(12):3702-9.
-
(2002)
Clin Cancer Res
, vol.8
, Issue.12
, pp. 3702-3709
-
-
Giaccone, G.1
Punt, C.J.A.2
Ando, Y.3
Ruijter, R.4
Nishi, N.5
Peters, M.6
-
18
-
-
33947523413
-
Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma
-
Molling JW, Langius JAE, Langendijk JA, Leemans CR, Bontkes HJ, Van Der Vliet HJJ, et al. Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma. J Clin Oncol. 2007;25(7):862-8.
-
(2007)
J Clin Oncol
, vol.25
, Issue.7
, pp. 862-868
-
-
Molling, J.W.1
Langius, J.A.E.2
Langendijk, J.A.3
Leemans, C.R.4
Bontkes, H.J.5
van der Vliet, H.J.J.6
-
19
-
-
70350433785
-
Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders
-
Azakami K, Sato T, Araya N, Utsunomiya A, Kubota R, Suzuki K, et al. Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders. Blood. 2009;114(15):3208-15.
-
(2009)
Blood
, vol.114
, Issue.15
, pp. 3208-3215
-
-
Azakami, K.1
Sato, T.2
Araya, N.3
Utsunomiya, A.4
Kubota, R.5
Suzuki, K.6
-
20
-
-
10644270807
-
The peripheral blood Valpha24+ NKT cell numbers decrease in patients with haematopoietic malignancy
-
Yoneda K, Morii T, Nieda M, Tsukaguchi N, Amano I, Tanaka H, et al. The peripheral blood Valpha24+ NKT cell numbers decrease in patients with haematopoietic malignancy. Leuk Res. 2005;29(2):147-52.
-
(2005)
Leuk Res
, vol.29
, Issue.2
, pp. 147-152
-
-
Yoneda, K.1
Morii, T.2
Nieda, M.3
Tsukaguchi, N.4
Amano, I.5
Tanaka, H.6
-
21
-
-
0035478706
-
Loss of IFN-gamma production by invariant NK T cells in advanced cancer
-
Tahir SM, Cheng O, Shaulov A, Koezuka Y, Bubley GJ, Wilson SB, et al. Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J Immunol. 2001;167(7):4046-50.
-
(2001)
J Immunol
, vol.167
, Issue.7
, pp. 4046-4050
-
-
Tahir, S.M.1
Cheng, O.2
Shaulov, A.3
Koezuka, Y.4
Bubley, G.J.5
Wilson, S.B.6
-
22
-
-
0038543513
-
A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
-
Dhodapkar MV, Geller MD, Chang DH, Shimizu K, Fujii S-I, Dhodapkar KM, et al. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J Exp Med. 2003;197(12):1667-76.
-
(2003)
J Exp Med
, vol.197
, Issue.12
, pp. 1667-1676
-
-
Dhodapkar, M.V.1
Geller, M.D.2
Chang, D.H.3
Shimizu, K.4
Fujii, S.-I.5
Dhodapkar, K.M.6
-
23
-
-
84864001519
-
Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients
-
Rossignol A, Levescot A, Jacomet F, Robin A, Basbous S, Giraud C, et al. Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients. Eur J Immunol. 2012;42(7):1870-5.
-
(2012)
Eur J Immunol
, vol.42
, Issue.7
, pp. 1870-1875
-
-
Rossignol, A.1
Levescot, A.2
Jacomet, F.3
Robin, A.4
Basbous, S.5
Giraud, C.6
-
24
-
-
0028149568
-
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL
-
Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8(10):1640-5.
-
(1994)
Leukemia
, vol.8
, Issue.10
, pp. 1640-1645
-
-
Matutes, E.1
Owusu-Ankomah, K.2
Morilla, R.3
Garcia, M.J.4
Houlihan, A.5
Que, T.H.6
-
25
-
-
34547659116
-
Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cellclonotypic monoclonal antibody, 6B11
-
Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cellclonotypic monoclonal antibody, 6B11. Immunology. 2007;122(1):1-14.
-
(2007)
Immunology
, vol.122
, Issue.1
, pp. 1-14
-
-
Montoya, C.J.1
Pollard, D.2
Martinson, J.3
Kumari, K.4
Wasserfall, C.5
Mulder, C.B.6
-
26
-
-
0037406968
-
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia
-
Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med. 2003;348(18):1764-75.
-
(2003)
N Engl J Med
, vol.348
, Issue.18
, pp. 1764-1775
-
-
Crespo, M.1
Bosch, F.2
Villamor, N.3
Bellosillo, B.4
Colomer, D.5
Rozman, M.6
-
27
-
-
0343036151
-
Corrections to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cell cytotoxicity
-
Konjević G, Jurisić V, Spuzić I. Corrections to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cell cytotoxicity. J Immunol Methods. 1997;200(1-2):199-201.
-
(1997)
J Immunol Methods
, vol.200
, Issue.1-2
, pp. 199-201
-
-
Konjević, G.1
Jurisić, V.2
Spuzić, I.3
-
28
-
-
34447316133
-
Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood
-
Jing Y, Gravenstein S, Chaganty NR, Chen N, Lyerly KH, Joyce S, et al. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood. Exp Gerontol. 2007;42(8):719-32.
-
(2007)
Exp Gerontol
, vol.42
, Issue.8
, pp. 719-732
-
-
Jing, Y.1
Gravenstein, S.2
Chaganty, N.R.3
Chen, N.4
Lyerly, K.H.5
Joyce, S.6
-
29
-
-
83155164561
-
Distinct and overlapping effector functions of expanded human CD4+, CD8alpha+ and CD4-CD8alphainvariant natural killer T cells
-
O'Reilly V, Zeng SG, Bricard G, Atzberger A, Hogan AE, Jackson J, et al. Distinct and overlapping effector functions of expanded human CD4+, CD8alpha+ and CD4-CD8alphainvariant natural killer T cells. PLoS ONE. 2011;6(12):e28648.
-
(2011)
PLoS ONE
, vol.6
, Issue.12
-
-
O'Reilly, V.1
Zeng, S.G.2
Bricard, G.3
Atzberger, A.4
Hogan, A.E.5
Jackson, J.6
-
30
-
-
44349166431
-
Blood dendritic cells in patients with chronic lymphocytic leukaemia
-
Mami N, Mohty M, Aurranschleinitz T, Olive D, Gaugler B. Blood dendritic cells in patients with chronic lymphocytic leukaemia. Immunobiology. 2008;213(6): 493-8.
-
(2008)
Immunobiology
, vol.213
, Issue.6
, pp. 493-498
-
-
Mami, N.1
Mohty, M.2
Aurranschleinitz, T.3
Olive, D.4
Gaugler, B.5
-
31
-
-
0036242830
-
T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia--the three-color flow cytometry analysis
-
Podhorecka M, Dmoszynska A, Rolinski J, Wasik E. T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia--the three-color flow cytometry analysis. Leuk Res. 2002;26(7):657-60.
-
(2002)
Leuk Res
, vol.26
, Issue.7
, pp. 657-660
-
-
Podhorecka, M.1
Dmoszynska, A.2
Rolinski, J.3
Wasik, E.4
-
32
-
-
34548838819
-
An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity
-
Chung Y, Qin H, Kang C-Y, Kim S, Kwak LW, Dong C. An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity. Blood. 2007;110(6):2013-9.
-
(2007)
Blood
, vol.110
, Issue.6
, pp. 2013-2019
-
-
Chung, Y.1
Qin, H.2
Kang, C.-Y.3
Kim, S.4
Kwak, L.W.5
Dong, C.6
-
33
-
-
77957761029
-
Invariant natural killer T cells and asthma: Immunologic reality or methodologic artifact?
-
Brooks CR, Weinkove R, Hermans IF, van Dalen CJ, Douwes J. Invariant natural killer T cells and asthma: immunologic reality or methodologic artifact? J Allergy Clin Immunol. 2010;126(4):882-5.
-
(2010)
J Allergy Clin Immunol
, vol.126
, Issue.4
, pp. 882-885
-
-
Brooks, C.R.1
Weinkove, R.2
Hermans, I.F.3
van Dalen, C.J.4
Douwes, J.5
-
34
-
-
79251497664
-
Presumed guilty: Natural killer T cell defects and human disease
-
Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol. 2011;11(2):131-42.
-
(2011)
Nat Rev Immunol
, vol.11
, Issue.2
, pp. 131-142
-
-
Berzins, S.P.1
Smyth, M.J.2
Baxter, A.G.3
-
35
-
-
77954659957
-
Immune recovery after fludarabine-cyclophosphamiderituximab treatment in B-chronic lymphocytic leukemia: Implication for maintenance immunotherapy
-
Ysebaert L, Gross E, Kuhlein E, Blanc A, Corre J, Fournie JJ, et al. Immune recovery after fludarabine-cyclophosphamiderituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy. Leukemia. 2010;24(7): 1310-6.
-
(2010)
Leukemia
, vol.24
, Issue.7
, pp. 1310-1316
-
-
Ysebaert, L.1
Gross, E.2
Kuhlein, E.3
Blanc, A.4
Corre, J.5
Fournie, J.J.6
-
36
-
-
0036936831
-
Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells
-
Zheng Z, Venkatapathy S, Rao G, Harrington CA. Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells. Leukemia. 2002;16(12):2429-37.
-
(2002)
Leukemia
, vol.16
, Issue.12
, pp. 2429-2437
-
-
Zheng, Z.1
Venkatapathy, S.2
Rao, G.3
Harrington, C.A.4
-
37
-
-
80052676080
-
The diagnostic value of CD1d expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders
-
Kotsianidis I, Nakou E, Spanoudakis E, Bouchliou I, Moustakidis E, Miltiades P, et al. The diagnostic value of CD1d expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders. Am J Clin Pathol. 2011;136(3):400-8.
-
(2011)
Am J Clin Pathol
, vol.136
, Issue.3
, pp. 400-408
-
-
Kotsianidis, I.1
Nakou, E.2
Spanoudakis, E.3
Bouchliou, I.4
Moustakidis, E.5
Miltiades, P.6
-
38
-
-
84880275610
-
Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia
-
Jadidi-Niaragh F, Jeddi-Tehrani M, Ansaripour B, Razavi SM, Sharifian RA, Shokri F. Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia. Med Oncol. 2012; 29(5):3561-9.
-
(2012)
Med Oncol
, vol.29
, Issue.5
, pp. 3561-3569
-
-
Jadidi-Niaragh, F.1
Jeddi-Tehrani, M.2
Ansaripour, B.3
Razavi, S.M.4
Sharifian, R.A.5
Shokri, F.6
-
39
-
-
1342309587
-
CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes
-
Fais F, Morabito F, Stelitano C, Callea V, Zanardi S, Scudeletti M, et al. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes. Int J Cancer. 2004;109(3):402-11.
-
(2004)
Int J Cancer
, vol.109
, Issue.3
, pp. 402-411
-
-
Fais, F.1
Morabito, F.2
Stelitano, C.3
Callea, V.4
Zanardi, S.5
Scudeletti, M.6
-
40
-
-
0034569025
-
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
-
Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD, et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol. 2000;1(6):515-20.
-
(2000)
Nat Immunol
, vol.1
, Issue.6
, pp. 515-520
-
-
Terabe, M.1
Matsui, S.2
Noben-Trauth, N.3
Chen, H.4
Watson, C.5
Donaldson, D.D.6
-
41
-
-
7244219944
-
Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines
-
Lin H, Nieda M, Nicol AJ. Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines. Eur J Immunol. 2004;34(10):2664-71.
-
(2004)
Eur J Immunol
, vol.34
, Issue.10
, pp. 2664-2671
-
-
Lin, H.1
Nieda, M.2
Nicol, A.J.3
-
42
-
-
67650770690
-
Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms
-
Bagnara D, Ibatici A, Corselli M, Sessarego N, Tenca C, De Santanna A, et al. Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms. Haematologica. 2009;94(7):967-74.
-
(2009)
Haematologica
, vol.94
, Issue.7
, pp. 967-974
-
-
Bagnara, D.1
Ibatici, A.2
Corselli, M.3
Sessarego, N.4
Tenca, C.5
De Santanna, A.6
|